ARVN
Price
$8.45
Change
-$0.26 (-2.99%)
Updated
Sep 11 closing price
Capitalization
552.51M
59 days until earnings call
Intraday BUY SELL Signals
BCYC
Price
$3.86
Change
+$0.03 (+0.78%)
Updated
Sep 11 closing price
Capitalization
270.87M
47 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ARVN vs BCYC

ARVN vs BCYC Comparison Chart in %
View a ticker or compare two or three
VS
ARVN vs. BCYC commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARVN is a Hold and BCYC is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARVN($553M) has a higher market cap than BCYC($271M). ARVN YTD gains are higher at: -28.752 vs. BCYC (-45.480). ARVN has higher annual earnings (EBITDA): -13.3M vs. BCYC (-183.2M). ARVN has more cash in the bank: 568M vs. BCYC (510M). ARVN has less debt than BCYC: ARVN (8M) vs BCYC (14.7M). ARVN has higher revenues than BCYC: ARVN (317M) vs BCYC (61.2M).
ARVNBCYCARVN / BCYC
Capitalization553M271M204%
EBITDA-13.3M-183.2M7%
Gain YTD-28.752-45.48063%
P/E Ratio32.50N/A-
Revenue317M61.2M518%
Total Cash568M510M111%
Total Debt8M14.7M54%
FUNDAMENTALS RATINGS
ARVN vs BCYC: Fundamental Ratings
ARVN
BCYC
OUTLOOK RATING
1..100
7056
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
9
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8297
PRICE GROWTH RATING
1..100
5774
P/E GROWTH RATING
1..100
48100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BCYC's Valuation (9) in the null industry is significantly better than the same rating for ARVN (80) in the Biotechnology industry. This means that BCYC’s stock grew significantly faster than ARVN’s over the last 12 months.

BCYC's Profit vs Risk Rating (100) in the null industry is in the same range as ARVN (100) in the Biotechnology industry. This means that BCYC’s stock grew similarly to ARVN’s over the last 12 months.

ARVN's SMR Rating (82) in the Biotechnology industry is in the same range as BCYC (97) in the null industry. This means that ARVN’s stock grew similarly to BCYC’s over the last 12 months.

ARVN's Price Growth Rating (57) in the Biotechnology industry is in the same range as BCYC (74) in the null industry. This means that ARVN’s stock grew similarly to BCYC’s over the last 12 months.

ARVN's P/E Growth Rating (48) in the Biotechnology industry is somewhat better than the same rating for BCYC (100) in the null industry. This means that ARVN’s stock grew somewhat faster than BCYC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARVNBCYC
RSI
ODDS (%)
Bearish Trend 2 days ago
67%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 11 days ago
79%
Bullish Trend 23 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
87%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (ARVN: $8.45 vs. BCYC: $3.86)
Brand notoriety: ARVN and BCYC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARVN: 108% vs. BCYC: 213%
Market capitalization -- ARVN: $552.51M vs. BCYC: $270.87M
ARVN [@Biotechnology] is valued at $552.51M. BCYC’s [@Biotechnology] market capitalization is $270.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARVN’s FA Score shows that 0 FA rating(s) are green while BCYC’s FA Score has 1 green FA rating(s).

  • ARVN’s FA Score: 0 green, 5 red.
  • BCYC’s FA Score: 1 green, 4 red.
According to our system of comparison, ARVN is a better buy in the long-term than BCYC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARVN’s TA Score shows that 4 TA indicator(s) are bullish while BCYC’s TA Score has 4 bullish TA indicator(s).

  • ARVN’s TA Score: 4 bullish, 5 bearish.
  • BCYC’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both ARVN and BCYC are a bad buy in the short-term.

Price Growth

ARVN (@Biotechnology) experienced а -10.01% price change this week, while BCYC (@Biotechnology) price change was -10.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

ARVN is expected to report earnings on Nov 10, 2026.

BCYC is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ARVN
Daily Signal:
Gain/Loss:
BCYC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EQTKX17.050.17
+1.01%
Shelton Equity Income Class K
IEOHX17.78N/A
N/A
Voya Large Cap Growth Port I
JDBAX49.40N/A
N/A
Janus Henderson Balanced A
MRIMX27.97N/A
N/A
Victory Integrity Mid-Cap Value R6
QCGDX16.39N/A
N/A
Quantified Common Ground Investor

ARVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARVN has been loosely correlated with AXON. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ARVN jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARVN
1D Price
Change %
ARVN100%
-2.99%
AXON - ARVN
46%
Loosely correlated
+0.10%
VCYT - ARVN
46%
Loosely correlated
-2.76%
OLMA - ARVN
45%
Loosely correlated
-4.40%
BCYC - ARVN
44%
Loosely correlated
+0.78%
KURA - ARVN
44%
Loosely correlated
-1.56%
More

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with DNLI. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
+0.78%
DNLI - BCYC
48%
Loosely correlated
-1.45%
PCVX - BCYC
48%
Loosely correlated
+0.97%
MGTX - BCYC
47%
Loosely correlated
-0.47%
BHVN - BCYC
46%
Loosely correlated
-0.63%
NGNE - BCYC
46%
Loosely correlated
-1.77%
More